ALENDRONATE-CONTAINING ORAL LIQUID COMPOSITIONS

摘要

medicine, pharmacy. SUBSTANCE: invention relates to method of treatment and prophylaxis of bone thinning in patients by administration of alendronate liquid composition that can be swallowed easily. Invention describes also pharmaceutical dosed forms of alendronate as syrup, an aqueous solution or solution prepared by power dissolving to realize the therapeutical method described. These compositions can be administrated in patients having difficulty in swallowing. EFFECT: improved medicinal form and stability of drug. 25 cl, 3 ex